Arrowhead Pharmaceuticals Inc. (ARWR) Misses Q4 EPS by 131c
Tweet
Share
E-mailGet Alerts ARWR Hot Sheet
Price: $68.79 +3.47%
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
ALZN, ASPU, OCCI, More
Financial Fact:
Loss on sale of fixed assets, net: 0
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) reported Q4 EPS of ($1.92), $1.31 worse than the analyst estimate of ($0.61). Revenue for the quarter came in at $240.73 million.
For earnings history and earnings-related data on Arrowhead Pharmaceuticals Inc. (ARWR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- HP shares slide as tech giant forecasts 2027 PC market slump
- Endava CFO placed on leave amid accounting probe
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
